证券代码：002105 证券简称：信隆健康 公告编号：2025-027 深圳信隆健康产业发展股份有限公司 关于选举第八届董事会职工代表董事的公告 深圳信隆健康产业发展股份有限公司（以下简称：公司）第七届董事会任期 届满，根据《中华人民共和国公司法》《公司章程》《公司职工代表大会制度》 的相关规定，第七届职工代表大会第一次会议于2025年8月5日上午09:00～10:00 在公司办公楼B栋二楼会议室召开，共有职工代表100人出席会议，本次会议符合 《公司法》《公司章程》及《公司职工代表大会制度》的规定，会议有效。会议 经讨论审议并通过了下列决议： 姜绍刚 先生简历如下： 姜绍刚 先生出生于1958年7月，中国国籍，籍贯台湾，大学本科毕业。姜绍 刚先生为公司第七届董事会董事、HL CORP(USA) 董事（1991年6月迄今）/总经 理（2005年1月迄今）。未持有本公司股票。与本公司第一大股东或实际控制人 不存在关联关系。没有受过中国证监会及其他有关部门的处罚和证券交易所惩戒。 特此公告。 深圳信隆健康产业发展股份有限公司董事会 2025年8月7日 经职工代表大会决议，一致同意选举姜绍刚先生为公司第八届董事会职 ...

Performance Forecast - The company expects a net loss of 9.5 million yuan for the first half of 2025, compared to a loss of 19 million yuan in the same period last year, indicating a significant improvement in performance [1] - The net profit attributable to shareholders is projected to decrease by 245.53% compared to the previous year, with a basic earnings per share loss of 0.026 yuan, an improvement from a loss of 0.052 yuan per share in the prior year [1] - The company anticipates a loss of 14.5 million yuan after deducting non-recurring losses, compared to a loss of 24 million yuan in the same period last year, reflecting a substantial decrease in losses [1] Reasons for Performance Change - The primary reason for the decline in net profit is attributed to market changes that have led to fluctuations in customer demand, resulting in revenue not meeting expectations and a decrease in gross profit [1] - The operating profit was insufficient to cover the period expenses, leading to the reported losses [1] Communication with Auditors - The financial data related to this performance forecast has not been audited by the accounting firm [1]

[Core Performance Forecast](index=1&type=section&id=%E4%B8%80%E3%80%81%E6%9C%AC%E6%9C%9F%E4%B8%9A%E7%BB%A9%E9%A2%84%E8%AE%A1%E6%83%85%E5%86%B5) The company anticipates a shift from profit to loss in the first half of 2025, with net profit attributable to shareholders projected to be a loss of RMB 9.5 million to RMB 19 million, representing a year-on-year decrease of 245.53% to 391.05% compared to the prior year's profit of RMB 6.528 million Performance Forecast Data | Item | Current Reporting Period (Jan 1 - Jun 30, 2025) | Prior Year Same Period | | :--- | :--- | :--- | | **Net Profit Attributable to Shareholders** | Loss: RMB 9.5 million – RMB 19 million | Profit: RMB 6.528 million | | Year-on-year Change | Decrease: 245.53% – 391.05% | - | | **Net Profit After Non-recurring Gains and Losses** | Loss: RMB 14.5 million – RMB 24 million | Profit: RMB 3.8758 million | | Year-on-year Change | Decrease: 474.12% - 719.23% | - | | **Basic Earnings Per Share** | Loss: RMB 0.026/share – RMB 0.052/share | Profit: RMB 0.018/share | [Communication with Accounting Firm](index=1&type=section&id=%E4%BA%8C%E3%80%81%E4%B8%8E%E4%BC%9A%E8%AE%A1%E5%B8%88%E4%BA%8B%E5%8A%A1%E6%89%80%E6%B2%9F%E9%80%9A%E6%83%85%E5%86%B5) The financial data presented in this performance forecast are preliminary estimates by the company and have not been audited by an accounting firm - The financial data related to this performance forecast have not been audited by an accounting firm[4](index=4&type=chunk) [Analysis of Performance Change](index=1&type=section&id=%E4%B8%89%E3%80%81%E4%B8%9A%E7%BB%A9%E5%8F%98%E5%8A%A8%E5%8E%9F%E5%9B%A0%E8%AF%B4%E6%98%8E) The primary reason for the performance decline is market environment changes leading to fluctuations in customer demand, resulting in the company's operating revenue falling short of expectations, which in turn caused a decrease in gross profit, insufficient to cover period expenses, ultimately leading to operating losses - The company's net profit decreased during the reporting period, primarily due to market changes causing fluctuations in customer demand, leading to the company's revenue falling short of expectations, a decline in gross profit, and operating profit being insufficient to cover period expenses, resulting in a loss[5](index=5&type=chunk) [Other Relevant Explanations and Risk Warning](index=1&type=section&id=%E5%9B%9B%E3%80%81%E5%85%B6%E4%BB%96%E7%9B%B8%E5%85%B3%E8%AF%B4%E6%98%8E) The company emphasizes that this performance forecast is a preliminary estimate by the finance department, and the final data will be subject to the 2025 semi-annual report to be disclosed, advising investors to make cautious decisions and be aware of investment risks - This performance forecast is a preliminary estimate by the company's finance department, unaudited, with specific data subject to the company's disclosed 2025 semi-annual report[6](index=6&type=chunk) - The company advises investors to make cautious decisions and be aware of investment risks[8](index=8&type=chunk)

Group 1 - The major shareholder, Litian Development Co., Ltd., plans to reduce its stake in Shenzhen Xinlong Health Industry Development Co., Ltd. by selling 3,680,600 shares, which represents 1% of the total share capital [1][2] - Litian Development currently holds 154,522,500 shares, accounting for 41.98% of the company's total share capital, all of which are tradable shares without restrictions [1][2] - The reduction will occur within 90 trading days starting from 15 trading days after the announcement, through either centralized bidding or block trading on the stock exchange [2] Group 2 - The reduction plan aligns with previously disclosed intentions and commitments by the shareholder [2] - As of the announcement date, Litian Development does not fall under any restrictions outlined in the Shenzhen Stock Exchange's self-regulatory guidelines regarding shareholder reductions [2]

证券代码：002105 证券简称：信隆健康 公告编号： 2025-025 公司持股5%以上的股东利田发展有限公司保证向本公司提供的信息内容真实、准 确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 深圳信隆健康产业发展股份有限公司（以下简称"公司"）现持股154,522,500股 （占公司总股本比例41.98%）的股东利田发展有限公司计划自本公告披露之日起十五个 交易日后的任意连续90个自然日内，通过证券交易所集中竞价或者大宗交易的方式减持 公司股份3,680,600股（占公司总股本比例1%）。 公司收到公司持股5%以上股东利田发展有限公司《拟减持股份的告知函》，计划自 本公告披露之日起十五个交易日后的任意连续90个自然日内，通过证券交易所集中竞价 或者大宗交易方式减持公司股份3,680,600股，即不超过公司总股本的1%。现将有关情况 公告如下： 一、股东的基本情况 （一）股东名称：利田发展有限公司 （二）持股情况：利田发展有限公司现持有公司股份154,522,500股，占公司总股本 比例41.98%，全部为无限售条件流通股。 深 ...

Group 1 - The major shareholder, Litian Development Co., Ltd., plans to reduce its stake in Xinlong Health (002105) by selling 3.6806 million shares, which represents 1% of the company's total share capital [1] - The share reduction will occur within a period of 90 natural days, starting from the 15th trading day after the announcement [1] - The shares will be sold through either centralized bidding on the stock exchange or through block trading [1]

Group 1 - The shared bicycle concept sector rose by 0.96%, ranking 8th among concept sectors, with four stocks increasing in value, including Hemei Group which hit the daily limit, and Zhongbei Communication, Aima Technology, and Yong'an Xing showing gains of 4.90%, 1.81%, and 0.09% respectively [1][2] - The leading stocks in terms of net inflow of main funds were Zhongbei Communication with a net inflow of 115 million yuan, followed by Aima Technology, Hemei Group, and Yong'an Xing with net inflows of 32.6 million yuan, 29 million yuan, and 3.9 million yuan respectively [2][3] - The net inflow ratios for Hemei Group, Zhongbei Communication, and Aima Technology were 20.63%, 13.31%, and 6.45% respectively, indicating strong investor interest in these stocks [3][4] Group 2 - The overall market saw various concept sectors with notable performance, including childcare services at 1.82% and short drama games at 1.25%, while the shipbuilding sector declined by 2.12% [2] - The shared bicycle sector's performance was supported by significant capital inflow, with a total net inflow of 124 million yuan, reflecting positive sentiment towards the sector [2][3] - Stocks such as Hemei Group and Zhongbei Communication demonstrated high turnover rates of 3.30% and 8.91% respectively, indicating active trading and investor engagement [3][4]

Core Viewpoint - The recent policy announcement by the Ministry of Industry and Information Technology and the Ministry of Civil Affairs aims to promote the development of smart elderly care service robots, which is expected to significantly boost the industry and accelerate technology implementation and market penetration [1][2]. Industry Overview - China's aging population is accelerating, leading to a surge in demand for elderly care services, while resources remain scarce. The rapid development of AI technology presents new solutions for the elderly care industry, making the smart elderly care robot market a focal point [2]. - According to a report by Founder Securities, the market size of the smart elderly care robot industry is projected to reach approximately 7.9 billion yuan in 2024, with rehabilitation robots accounting for the largest share at 45%. Emotional companionship robots are expected to grow at a remarkable annual rate of 120%, with the market size potentially exceeding 50 billion yuan by 2025 [2]. Company Developments - Several listed companies are actively entering the smart elderly care robot sector. For instance, Xilong Health has indicated that smart rehabilitation assistive devices, including smart wheelchairs and exoskeleton robots, are key development areas, although no mature products have been launched yet [2]. - Ousheng Electric has gained a competitive edge with its new intelligent nursing robot, which can automatically sense and identify the status of disabled patients, significantly improving care efficiency and patient comfort [2]. - Medisdon Medical Technology has formed strategic partnerships to integrate medical information technology with elderly care robotics, aiming to create a comprehensive solution platform for smart elderly care [3]. Market Challenges - Despite the promising outlook for the smart elderly care robot industry, there are challenges such as the need for improved environmental perception and adaptability in complex settings, as well as high production costs due to expensive raw materials [5][6]. - The market is becoming increasingly competitive, with many companies entering the field, leading to potential homogenization of products. Some companies are rushing to launch products without mature technology, resulting in varying product quality [5][6]. - Companies must focus on continuous R&D investment, mastering core technologies, and optimizing cost control to succeed in this competitive landscape [6].

Core Insights - The Ministry of Industry and Information Technology (MIIT) and the Ministry of Civil Affairs are promoting pilot projects for elderly care robots, planning to deploy at least 200 units for family applications to address the increasing aging population and shortage of caregiving resources in China [1][3][7] Industry Overview - China's aging population is rapidly increasing, with 310 million people aged 60 and above, accounting for 22% of the total population. The number of people aged 65 and above is 220 million, representing 15.6% [3] - The demand for elderly care is surging due to declining marriage rates and a clear trend of fewer children, leading to a significant shortage of caregiving resources, with millions of caregiver vacancies and a lack of public nursing homes [3][4] Policy Support - National policies are increasingly supporting the application of smart robots in elderly care, as outlined in the "Smart Health and Elderly Care Industry Development Action Plan (2021-2025)," which identifies elderly care robots as a core direction for smart elderly care devices [3][4] - The "Opinions on Deepening the Reform and Development of Elderly Care Services" issued in January emphasizes the development of a comprehensive elderly care service network by 2029, with a focus on humanoid robots and AI technologies [3] Market Dynamics - The smart elderly care robot market in China has been rapidly expanding, reaching nearly 25 billion yuan in 2023, with projections suggesting it could reach a trillion yuan market by 2030 [5] - The penetration rates for health monitoring products are around 10%, while rehabilitation, nursing, and emotional support robots have a penetration rate of about 5% [5] Challenges and Opportunities - The industry faces challenges such as a significant gap in caregiving for disabled individuals, insufficient emotional companionship for elderly living alone, and a lack of service supply in lower-tier cities and rural areas [4][6] - The MIIT's recent initiative aims to address existing product shortcomings and validate applications in home, community, and institutional settings, with a focus on various caregiving scenarios [6][7]

在换届选举工作完成之前，公司第七届董事会和监事会全体成员、董事会各专门委员会 委员及高级管理人员将按照法律法规和《深圳信隆健康产业发展股份有限公司章程》的规定 继续履行职责。 本次延期换届不会影响公司正常运营。公司将积极推进相关工作，并及时履行信息披露 义务。 证券代码：002105 证券简称：信隆健康 公告编号： 2025-024 深圳信隆健康产业发展股份有限公司 关于董事会、监事会延期换届的提示性公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导 性陈述或重大遗漏。 深圳信隆健康产业发展股份有限公司（以下简称"公司"）第七届董事会、监事会任期 临近届满。 鉴于公司新一届董事会和监事会的换届选举工作尚在积极筹备中，为保持董事会、监事 会有关工作的连续性和稳定性，公司董事会、监事会的换届选举工作将适当延期，公司董事 会各专门委员会委员及高级管理人员的任期亦相应顺延。 特此公告。 深圳信隆健康产业发展股份有限公司 董 事 会 2025 年 05 月 24 日 ...